Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cigna Corp (NY: CI )

317.46 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Oct 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 317.46
Bid (Size) 314.10 (1)
Ask (Size) 322.99 (2)
Prev. Close 317.46
Today's Range 317.46 - 317.46
52wk Range 253.95 - 370.82
Shares Outstanding 340,107,539
Dividend Yield 1.55%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Why Cigna Group Stock Got Mashed on Monday
A media report stated that the company is determined to grow with a major merger deal. 
Via The Motley Fool
Stocks Fall As Treasury Yields, Dollar Rise; Nvidia Hits Record Highs: What's Driving Markets Monday?
U.S. major indices fell on Monday as rising Treasury yields and a strengthening dollar dampened risk sentiment. Investors are reassessing the economic outlook and weighing potential risks tied to the... 
Via Benzinga

Performance

YTD
+2.37%
+2.37%
1 Month
-10.56%
-10.56%
3 Month
-5.57%
-5.57%
6 Month
-9.98%
-9.98%
1 Year
+5.45%
+5.45%

More News

Read More
Cigna And Humana Revive Early Merger Talks After Year-Long Pause As Medicare Cost Pressure Looms
Via Benzinga
Cigna-Humana Merger Talks Back On With Tables Turned; 2024 Election Is Key
Via Investor's Business Daily
$100 Invested In This Stock 15 Years Ago Would Be Worth $1,200 Today
Via Benzinga
A Glimpse Into The Expert Outlook On Cigna Through 11 Analysts
Via Benzinga
NYSE:CI: good value for what you're paying.
Via Chartmill
Market Briefing For Monday, Oct 21
Via Talk Markets
SAP, Nucor And 3 Stocks To Watch Heading Into Monday
Via Benzinga
Pharmacy Retailer CVS Health Backs Away From Annual Forecast, Names New CEO
Via Benzinga
CVS, UnitedHealth Request FTC Chair Recusal Amid Ongoing Pharmacy Benefit Managers Lawsuit
Via Benzinga
NYSE:CI is showing good growth, while it is not too expensive.
Via Chartmill
If You Invested $1000 In This Stock 15 Years Ago, You Would Have $12,000 Today
Via Benzinga
Ready for Open Enrollment? 4 Tips for Choosing the Right Medicare Plan
Via StatePoint Media
(CI) - Analyzing Cigna's Short Interest
Via Benzinga
3 Dividend Growth Stocks Set to Supercharge Your Portfolio
Via MarketBeat
Topics ETFs
Shamus McGuire Champions Advanced Technology Integration in New Jersey’s Healthcare Sector
Via Get News
Topics Artificial Intelligence
Exposures Artificial Intelligence
Texas Attorney General Sues Insulin Manufacturers and Pharmacy Benefit Managers Over Price-Fixing Conspiracy That Increased Prices by 1,000%
Via Benzinga
Topics Lawsuit
Exposures Financial Legal
Healthcare Executive Shamus McGuire Highlights Work-Life Balance in New Jersey
Via Zexprwire
CVS Health Mulls Split Of Retail And Insurance Divisions To Address Financial Challenges: Report
Via Benzinga
CVS Health in Focus as Activist Investor Prepares for High-Level Talks
Via Benzinga
Are CVS Health, Cigna, and UnitedHealth Group Stocks Bad News Buys With the FTC's PBM Crackdown?
Via The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
UnitedHealth Vs. CVS Vs. Cigna: Which Health Stock Will Beat The FTC's Regulatory Heat?
Via Benzinga
Topics Lawsuit
Exposures Financial Legal
US Federal Trade Commission Sues CVS Health, Cigna, UnitedHealth's Pharmacy Benefit Managers For Inflating Insulin Prices
Via Benzinga
Topics Lawsuit
Exposures Financial Legal
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.